Eminence Capital LP boosted its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 52.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 249,247 shares of the semiconductor company’s stock after acquiring an additional 85,818 shares during the quarter. Synopsys accounts for approximately 1.9% of Eminence Capital LP’s investment portfolio, making the stock its 25th biggest position. Eminence Capital LP’s holdings in Synopsys were worth $117,076,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Sowell Financial Services LLC boosted its stake in shares of Synopsys by 2.0% in the fourth quarter. Sowell Financial Services LLC now owns 1,056 shares of the semiconductor company’s stock valued at $496,000 after purchasing an additional 21 shares during the period. Natural Investments LLC increased its stake in Synopsys by 4.6% during the 4th quarter. Natural Investments LLC now owns 482 shares of the semiconductor company’s stock worth $226,000 after buying an additional 21 shares during the period. Financial Management Professionals Inc. lifted its holdings in Synopsys by 7.0% during the 4th quarter. Financial Management Professionals Inc. now owns 335 shares of the semiconductor company’s stock worth $157,000 after buying an additional 22 shares in the last quarter. Foronjy Financial LLC boosted its position in Synopsys by 5.2% in the 4th quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company’s stock valued at $210,000 after buying an additional 22 shares during the period. Finally, Barden Capital Management Inc. boosted its position in Synopsys by 1.2% in the 4th quarter. Barden Capital Management Inc. now owns 1,868 shares of the semiconductor company’s stock valued at $877,000 after buying an additional 23 shares during the period. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Synopsys News Roundup
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys announced the first wave of its Multiphysics Fusion solutions, which integrate multiphysics analysis into design workflows and could improve chip design speed, accuracy, and customer adoption. Synopsys Announces Availability of the First Wave of Multiphysics Fusion Solutions
- Positive Sentiment: Synopsys also expanded its ecosystem through a partnership with Murata to provide simulation models through Synopsys/Ansys electromagnetic and thermal analysis tools, a move that supports its engineering software platform. Murata Collaborates with Synopsys to Provide Simulation Models Through Ansys Electromagnetic and Thermal Analysis Tools
- Neutral Sentiment: A 247WallSt. commentary said SNPS has been stuck in a weak trading pattern this year, but still projected a year-end price target above current levels, reinforcing a mixed but not bearish long-term view. Synopsys Stock Will End The Year at This Price
- Neutral Sentiment: A DCF-based valuation piece said Synopsys looks fairly valued around $394, suggesting the stock may not be deeply undervalued despite recent weakness. SNPS Fairly Valued by DCF at 394
- Negative Sentiment: CEO Sassine Ghazi sold 14,603 shares and CFO Shelagh Glaser sold 3,394 shares under pre-arranged 10b5-1 plans, which may be routine but can still weigh on investor sentiment. Top Synopsys Executive Makes Major Move With Insider Stock Sale
- Negative Sentiment: Brokerage coverage continues to show a cautious stance overall, with consensus at “Hold,” which may limit enthusiasm despite solid earnings and revenue growth. Synopsys, Inc. Given Consensus Rating of Hold by Brokerages
Insider Activity at Synopsys
Synopsys Stock Performance
Shares of SNPS stock opened at $461.74 on Thursday. The company has a market cap of $88.41 billion, a P/E ratio of 106.88, a PEG ratio of 2.63 and a beta of 1.22. The firm has a fifty day moving average price of $477.08 and a 200 day moving average price of $461.83. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 12 month low of $376.18 and a 12 month high of $651.73.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The company had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s revenue for the quarter was up 41.9% on a year-over-year basis. During the same period in the previous year, the business earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Sell-side analysts predict that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of research firms have recently weighed in on SNPS. Piper Sandler upped their price objective on Synopsys from $430.00 to $450.00 and gave the stock a “neutral” rating in a research report on Thursday, May 28th. Robert W. Baird set a $558.00 target price on Synopsys in a research note on Thursday, May 28th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Synopsys in a research report on Monday, June 8th. Wells Fargo & Company lifted their price objective on Synopsys from $505.00 to $535.00 and gave the company an “equal weight” rating in a research note on Thursday, May 28th. Finally, BNP Paribas Exane boosted their price objective on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research report on Thursday, May 28th. Nine research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Synopsys presently has a consensus rating of “Hold” and a consensus price target of $563.81.
Check Out Our Latest Report on SNPS
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
